Physician profile
David E Goldgrab
NPI 1144675331
$4,134.53
in general payments reported to CMS, 2019-2025
15 companies · $739 in 2025
The $739 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $172 · 2022: $652 · 2023: $2,204 · 2024: $367 · 2025: $739.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,381 · Travel and Lodging: $929.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,381.06 |
| Travel and Lodging | $929.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,917.21 | 2022-2023 | Optis, Xience Sierra, Confirm Rx |
| Shockwave Medical, INC | $560.73 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $408.01 | 2021-2025 | Emblem Mri S-Icd |
| Cardiovascular Systems INC. | $233.73 | 2023 | Diamondback Peripheral, Diamondback Coronary |
| Cardiva Medical, INC. | $227.93 | 2022 | |
| Medtronic, INC. | $148.75 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $140.00 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $125.00 | 2025 | Lokelma |
| Kestra Medical Technology Services, INC. | $106.83 | 2024-2025 | Assure Wcd |
| Haemonetics Corporation | $101.56 | 2023 | |
| Edwards Lifesciences Corporation | $63.26 | 2022-2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Pfizer INC. | $36.33 | 2025 | |
| Abiomed | $24.64 | 2025 | |
| W. L. Gore & Associates, INC. | $20.29 | 2023 | Gore Excluder Aaa Endoprosthesis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.26 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Goldgrab listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.